China Medical University Hospital (CMUH)
↗Taichung, Taiwan
China Medical University Hospital (CMUH) is a premier academic medical center and research institution located in Taichung, Taiwan. Founded in 1980, it serves as the flagship hospital of the China Medical University Healthcare System, which comprises 22 institutions and over 6,000 employees. CMUH is internationally recognized as a 'Smart Hospital' leader, having achieved HIMSS DIAM Stage 7 certification and multiple accolades for its integration of AI and digital health technologies.
Beyond clinical care, CMUH is a major hub for biomedical innovation, particularly in regenerative medicine, cell therapy, and precision oncology. The hospital operates a robust translational research ecosystem, fostering several high-growth biotech spin-offs such as Ever Supreme Bio-Technology and Ever Fortune AI. CMUH actively collaborates with global technology giants like Google Cloud and Microsoft to develop generative AI tools for clinical diagnostics and drug discovery, positioning itself as a critical partner for pharmaceutical companies conducting multicenter clinical trials in the Asia-Pacific region.
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:
Industry:Biotechnology
Sub-Industry:Cell and Gene Therapy / Clinical Research
SIZE & FINANCIALS
Employees:5001-10000
Revenue:$100M-$500M
Founded:1980
Ownership:nonprofit
Status:operating
FUNDING
Investors:China Medical University, Ministry of Health and Welfare (Taiwan) - via research grants
PIPELINE
Stage:Phase 2
Lead Drug Stage:Phase 2
Modalities:Cell therapy, Gene therapy, Exosomes, mRNA, Digital Health/AI, Small molecule
Active Trials:124
Trial Phases:Phase 1: 42 | Phase 2: 58 | Phase 3: 18 | Phase 4: 6
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Parent Company:China Medical University Healthcare System
Subsidiaries:Ever Supreme Bio-Technology Co., Ltd. (TPEX: 6712), Ever Fortune.AI Co., Ltd. (TPEX: 6841), Ever Young BioDimension Corp., EverBot Technology
Key Partnerships:Google Cloud (Generative AI & MedLM for cancer care), Microsoft (gHi medical speech AI engine), Avance Clinical (Global CRO partnership), Novartis (Clinical trials), Pfizer (Clinical trials), Sanofi (Clinical trials), Shine-On Biomedical (Exosome-based precision medicine)
COMPETITION
Position:Leader
Competitors:National Taiwan University Hospital (NTUH), Linkou Chang Gung Memorial Hospital, Taipei Veterans General Hospital, Samsung Medical Center (Regional)
LEADERSHIP
Key Executives:
Dr. Der-Yang Cho - Superintendent / CEO
Tsai Chang-hai - Chairman
Prof. Oscar K. Lee - Vice Superintendent
Scientific Founders:Tsai Chang-hai
Board Members:Tsai Chang-hai (Chairman), Mien-Chie Hung, Fuu-Jen Tsai
LINKS
Website:cmuh.org.tw
LinkedIn:LinkedIn Profile
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with China Medical University Hospital (CMUH). The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.